CA
BSX icon

Continuum Advisory’s Boston Scientific BSX Stock Holding History

Continuum Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-776
Closed -$78.3K – 561
2025
Q1 		$78.3K Sell
776
-137
-15% -$13.8K 0.01% 565
2024
Q4 		$81.5K Buy
913
+21
+2% +$1.85K 0.01% 563
2024
Q3 		$78.1K Buy
892
+18
+2% +$1.42K 0.01% 569
2024
Q2 		$67.3K Buy
874
+268
+44% +$19.6K 0.01% 562
2024
Q1 		$44.9K Buy
+606
New +$39K 0.01% 619

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Continuum Advisory's BSX Position: Q2 2025 in Review

Continuum Advisory sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 776 shares — an estimated $78.3K sold.

Continuum Advisory first reported a position in BSX in Q1 2024 and held it in 5 quarters. The position peaked at $81.5K in Q4 2024. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Continuum Advisory reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 776 Boston Scientific shares in Q2 2025, an estimated $78.3K.
  • Continuum Advisory first reported a position in Boston Scientific in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Boston Scientific position peaked at $81.5K in Q4 2024.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.